Institutional members access full text with Ovid®

Share this article on:

Will “Improbable Resistance” Become of Daily Concern?

Tulkens, Paul M. MD, PhD

Infectious Diseases in Clinical Practice: March 2013 - Volume 21 - Issue 2 - p 75–76
doi: 10.1097/IPC.0b013e3182882d21
Editorial Comments

From the Cellular and Molecular Pharmacology, Louvain Drug Research Institute, Université catholique de Louvain, Brussels, Belgium.

Correspondence to: Paul M. Tulkens, MD, PhD, Université de catholique de Louvain, avenue E. Mounier 73 Bte B1.73.05, B-1200, Bruxelles, Belgium. E-mail: tulkens@facm.ucl.ac.be.

The author has no funding or conflicts of interest to disclose.

© 2013 by Lippincott Williams & Wilkins.